BOTOX® Treatment in Pediatric Upper Limb Spasticity
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 235 participants.
Also called NCT01603602
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 235 participants
- Sponsor
- Allergan
- Registry
-
NCT01603602 -
2012-000062-38
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada, Hungary, Philippines, Poland, Russia, South Korea, Thailand, Türkiye
- Registry status
- Completed
Technical summary
Registry record NCT01603602. Randomized; quadruple masking; primary purpose treatment. Start 2012-07-12 (actual); primary completion 2017-06-29 (actual). Results posted on 2018-08-14.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- BOTOX® Treatment in Pediatric Upper Limb Spasticity
- Condition
- Pediatrics
- Condition
- Muscle Spasticity
- Condition
- Cerebral Palsy
- Condition
- Stroke
- Intervention (Biological)
- botulinum toxin Type A
- Intervention (Drug)
- Normal Saline (Placebo)
- Lead sponsor
- Allergan
Record details
- Record id
cardio:ct-nct01603602- Content hash
024ca9536a1b74e5e28f46297f016852d076d472c868a9ab828a6619916bafb5